Vivera Pharmaceuticals names new CFO
12 January 2022 -

Vivera Pharmaceuticals, a United States-based pharmaceutical company, announced on Tuesday that it has named Donald D'Ambrosio as its new chief financial officer.

D'Ambrosio has more than four decades of experience serving in executive and officer roles within banking, investment, and finance companies. He also completed the acquisition and integration of Arcadian Telepsychiatry Services LLC and the reverse merger with Emmaus Life Sciences Inc. He funded and built Oxygen Funding Inc. He has held the position of senior vice president controller and CFO of BNC Mortgage Inc.

In the new role, D'Ambrosio is to direct and manage the firm's financial activities. He will also navigate transactions, handle risk, and work with external regulatory agencies related to capital raises to strengthen the company's long-term growth and financial performance.